|
1
|
Sankhe S, Manousakidi S, Antigny F, Arthur
Ataam J, Bentebbal S, Ruchon Y, Lecerf F, Sabourin J, Price L,
Fadel E, et al: T-type Ca2+ channels elicit
pro-proliferative and anti-apoptotic responses through impaired
PP2A/Akt1 signaling in PASMCs from patients with pulmonary arterial
hypertension. Biochim Biophys Acta. 1864:1631–1641. 2017.
View Article : Google Scholar
|
|
2
|
Humar R, Kiefer FN, Berns H, Resink TJ and
Battegay EJ: Hypoxia enhances vascular cell proliferation and
angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.
FASEB J. 16:771–780. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xia H, Diebold D, Nho R, Perlman D,
Kleidon J, Kahm J, Avdulov S, Peterson M, Nerva J, Bitterman P and
Henke C: Pathological integrin signaling enhances proliferation of
primary lung fibroblasts from patients with idiopathic pulmonary
fibrosis. J Exp Med. 205:1659–1672. 2015. View Article : Google Scholar
|
|
4
|
Lu Y, Azad N, Wang L, Iyer AK, Castranova
V, Jiang BH and Rojanasakul Y: Phosphatidylinositol-3-kinase/akt
regulates bleomycin-induced fibroblast proliferation and collagen
production. Am J Respir Cell Mol Biol. 42:432–441. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sato S, Fujita N and Tsuruo T:
Interference with PDK1-Akt survival signaling pathway by UCN-01
(7-hydroxystaurosporine). Oncogene. 21:1727–1738. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Orlacchio A, Arciuch VA and Cristofano AD:
PDK1-dependent activation of AGC kinases is an absolute requirement
for AKT oncogenic activity. Cancer Res. 74 (Suppl 19):4776.
2014.
|
|
7
|
Dupuy F, Tabariès S, Andrzejewski S, Dong
Z, Blagih J, Annis MG, Omeroglu A, Gao D, Leung S, Amir E, et al:
PDK1-dependent metabolic reprogramming dictates metastatic
potential in breast cancer. Cell Metab. 22:577–589. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li W, Qian L, Lin J, Huang G, Hao N, Wei
X, Wang W and Liang J: CD44 regulates prostate cancer
proliferation, invasion and migration via PDK1 and PFKFB4.
Oncotarget. 8:65143–65151. 2017.PubMed/NCBI
|
|
9
|
Fang B, Zhu J, Wang Y, Geng F and Li G:
MiR-454 inhibited cell proliferation of human glioblastoma cells by
suppressing PDK1 expression. Biomed Pharmacother. 75:148–152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu Y, Yang K, Sun X, Fang P, Shi H, Xu J,
Xie M and Li M: MiR-138 suppresses airway smooth muscle cell
proliferation through the PI3K/AKT signaling pathway by targeting
PDK1. Exp Lung Res. 41:363–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu ZL, Wang JN, Wu XH, Xie HJ, Han Y, Guan
YT, Qin Y and Jiang JM: Tanshinone IIA prevents rat basilar artery
smooth muscle cells proliferation by inactivation of PDK1 during
the development of hypertension. J Cardiovasc Pharmacol Ther.
20:563–571. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mora A, Davies AM, Bertrand L, Sharif I,
Budas GR, Jovanović S, Mouton V, Kahn CR, Lucocq JM, Gray GA, et
al: Deficiency of PDK1 in cardiac muscle results in heart failure
and increased sensitivity to hypoxia. EMBO J. 22:4666–4676. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Belgardt BF, Husch A, Rother E, Ernst MB,
Wunderlich FT, Hampel B, Klöckener T, Alessi D, Kloppenburg P and
Brüning JC: PDK1 deficiency in POMC-expressing cells reveals
FOXO1-dependent and-independent pathways in control of energy
homeostasis and stress response. Cell Metab. 7:291–301. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Papandreou I, Cairns RA, Fontana L, Lim AL
and Denko NC: HIF-1 mediates adaptation to hypoxia by actively
downregulating mitochondrial oxygen consumption. Cell Metab.
3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ciuclan L, Bonneau O, Hussey M, Duggan N,
Holmes AM, Good R, Stringer R, Jones P, Morrell NW, Jarai G, et al:
A novel murine model of severe pulmonary arterial hypertension. Am
J Respir Crit Care Med. 184:1171–1182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song Y, Coleman L, Shi J, Beppu H, Sato K,
Walsh K, Loscalzo J and Zhang YY: Inflammation, endothelial injury,
and persistent pulmonary hypertension in heterozygous BMPR2-mutant
mice. Am J Physiol Heart Circ Physiol. 295:H677–H690. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song Y, Jones JE, Beppu H, Keaney JF Jr,
Loscalzo J and Zhang YY: Increased susceptibility to pulmonary
hypertension in heterozygous BMPR2-mutant mice. Circulation.
112:553–562. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang J, Chu ES, Chen HY, Man K, Go MY,
Huang XR, Lan HY, Sung JJ and Yu J: microRNA-29b prevents liver
fibrosis by attenuating hepatic stellate cell activation and
inducing apoptosis through targeting PI3K/AKT pathway. Oncotarget.
6:7325–7338. 2015.PubMed/NCBI
|
|
19
|
Abdalla M, Sabbineni H, Prakash R, Ergul
A, Fagan SC and Somanath PR: The Akt inhibitor, triciribine,
ameliorates chronic hypoxia-induced vascular pruning and
TGFβ-induced pulmonary fibrosis. Br J Pharmacol. 172:4173–4188.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Larson-Casey JL, Murthy S, Ryan AJ and
Carter AB: Modulation of the mevalonate pathway by akt regulates
macrophage survival and development of pulmonary fibrosis. J Biol
Chem. 289:36204–36219. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang H, Chen J, Drennan AR, Fraidenburg
DR, Song S, Sysol JR, Smith KA, Machado RF, Makino A and Yuan JX:
Akt/mTOR signaling contributes to the development of pulmonary
arterial hypertension, in D27. Preclinical models of pulmonary
hypertension: Novel targets and pathways. Am Thoracic Soc.
189:A55592014.
|
|
22
|
Dai W, Xu X, Li S, Ma J, Shi Q, Guo S, Liu
L, Guo W, Xu P, He Y, et al: SOX4 promotes proliferative signals by
regulating glycolysis through AKT activation in melanoma cells. J
Invest Dermatol. 137:2407–2416. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dong Y, Liang G, Yuan B, Yang C, Gao R and
Zhou X: MALAT1 promotes the proliferation and metastasis of
osteosarcoma cells by activating the PI3K/Akt pathway. Tumor Biol.
36:1477–1486. 2015. View Article : Google Scholar
|
|
24
|
Allard D, Figg N, Bennett MR and
Littlewood TD: Akt regulates the survival of vascular smooth muscle
cells via inhibition of FoxO3a and GSK3. J Biol Chem.
283:19739–19747. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sato S, Fujita N and Tsuruo T:
Interference with PDK1-Akt survival signaling pathway by UCN-01
(7-hydroxystaurosporine). Oncogene. 21:1727–1738. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vander Haar E, Lee SI, Bandhakavi S,
Griffin TJ and Kim DH: Insulin signalling to mTOR mediated by the
Akt/PKB substrate PRAS40. Nat Cell Biol. 9:316–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai CX, Buddha H, Castelino-Prabhu S,
Zhang Z, Britton RS, Bacon BR and Neuschwander-Tetri BA: Activation
of insulin-PI3K/Akt-p70S6K pathway in hepatic stellate cells
contributes to fibrosis in nonalcoholic steatohepatitis. Dig Dis
Sci. 62:968–978. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Seufferlein T and Rozengurt E: Rapamycin
inhibits constitutive p70s6k phosphorylation, cell proliferation,
and colony formation in small cell lung cancer cells. Cancer Res.
56:3895–3897. 2004.
|
|
29
|
Syed DN, Chamcheu JC, Khan MI, Sechi M,
Lall RK, Adhami VM and Mukhtar H: Fisetin inhibits human melanoma
cell growth through direct binding to p70S6K and mTOR: Findings
from 3-D melanoma skin equivalents and computational modeling.
Biochem Pharmacol. 89:349–360. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chai X, Chu H, Yang X, Meng Y, Shi P and
Gou S: Metformin increases sensitivity of pancreatic cancer cells
to gemcitabine by reducing CD133+ cell populations and
suppressing ERK/P70S6K signaling. Scientific Reports. 5:144042015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li G, Shan C, Liu L, Zhou T, Zhou J, Hu X,
Chen Y, Cui H and Gao N: Tanshinone IIA inhibits HIF-1α and VEGF
expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1
signaling pathway. PLoS One. 10:e01174402015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Conejo R, de Alvaro C, Benito M, Cuadrado
A and Lorenzo M: Insulin restores differentiation of
Ras-transformed C2C12 myoblasts by inducing NF-kappaB through an
AKT/P70S6K/p38-MAPK pathway. Oncogene. 21:3739–3753. 2002.
View Article : Google Scholar : PubMed/NCBI
|
